- Product Web Site
- Prescribing Information
- Product Resources: 1-844-409-1141
Ivosidenib is used to treat patients with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-1 (IDH-1) mutation. Ivosidenib is also used to treat patients with cholangiocarcinoma with an isocitrate dehydrogenase-1 (IDH-1) mutation.
Our Medication Sheet
This sheet is available to download as an Adobe PDF.Get Ivosidenib Medication Sheet